Stay updated on Belantamab vs Bortezomib in MM Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the previous notices about government funding lapse and the Revision: v3.4.1 have been removed.
    Difference
    0.2%
    Check dated 2026-02-11T06:25:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a site-wide Notice about a lapse in government funding and that the NIH Clinical Center is open, with references to cc.nih.gov and opm.gov. Updated the platform revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T04:58:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The updates are UI and metadata changes, such as showing a glossary, adding related topic tags (Multiple Myeloma, MedlinePlus Genetics), and revision metadata; no core study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:15:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the related topics: 'Multiple myeloma' and 'MedlinePlus Genetics'. These are metadata entries used for indexing and do not affect the study content.
    Difference
    0.1%
    Check dated 2026-01-21T03:52:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page; no user-facing content or functional changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:35:42.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the Study Details page.
    Difference
    0.1%
    Check dated 2026-01-06T20:40:14.000Z thumbnail image

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.